|
HS Code |
228964 |
| Generic Name | Pregabalin |
| Brand Names | Lyrica, Lyrica CR |
| Drug Class | Anticonvulsant, Neuropathic pain agent |
| Indications | Neuropathic pain, Fibromyalgia, Epilepsy (partial seizures), Generalized anxiety disorder |
| Route Of Administration | Oral |
| Mechanism Of Action | Binds to α2δ subunit of voltage-gated calcium channels in CNS |
| Chemical Formula | C8H17NO2 |
| Pregnancy Category | Category C (US FDA) |
| Controlled Substance Status | Schedule V (US) |
| Common Side Effects | Dizziness, somnolence, dry mouth, edema, blurred vision, weight gain |
| Half Life | About 6.3 hours |
| Metabolism | Minimal hepatic metabolism |
| Excretion | Renal, primarily unchanged |
| Molecular Weight | 159.23 g/mol |
As an accredited Pregabalin factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Pregabalin packaging: White cardboard box, blue accents, labeled "Pregabalin 75 mg", containing 30 capsules in silver blister strips. |
| Shipping | Pregabalin is shipped in tightly sealed, moisture-resistant containers to ensure stability and prevent contamination. It must be stored and transported under controlled temperature conditions, typically below 25°C, and protected from light. Each shipment complies with regulations for handling pharmaceuticals, including proper documentation, secure packaging, and labeling according to hazard and safety requirements. |
| Storage | Pregabalin should be stored at room temperature, typically between 20°C to 25°C (68°F to 77°F), in a tightly closed container. Keep it away from moisture, heat, and direct light. Protect from excessive humidity and avoid freezing. Store out of reach of children and pets. Follow specific storage instructions provided by the manufacturer or pharmacist. |
|
Purity 99%: Pregabalin with a purity of 99% is used in neuropathic pain management, where consistent and reliable analgesic response is achieved. Particle size <10 µm: Pregabalin with particle size less than 10 µm is used in oral solid dosage formulations, where enhanced dissolution rate facilitates rapid therapeutic onset. Stability at 25°C: Pregabalin with stability at 25°C is used in pharmaceutical storage, where prolonged shelf life and maintained efficacy are ensured. Melting point 194–196°C: Pregabalin with a melting point of 194–196°C is used in quality-controlled synthesis, where batch-to-batch consistency in product integrity is ensured. Optical rotation -1.5° to -2.0°: Pregabalin with an optical rotation of -1.5° to -2.0° is used in chiral purity assessments, where enantiomeric excess provides predictable pharmacological activity. Water content <0.5%: Pregabalin with water content below 0.5% is used in moisture-sensitive formulations, where minimized hydrolysis risk supports stability and efficacy. Assay ≥98%: Pregabalin with assay not less than 98% is used in precision dosing regimens, where accuracy in active pharmaceutical ingredient content ensures therapeutic effectiveness. Residual solvent <100 ppm: Pregabalin with residual solvent content under 100 ppm is used in injectable formulation development, where reduced impurity levels safeguard patient safety. |
Competitive Pregabalin prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Every day, thousands face the kind of pain that keeps you up at night and chips away at simple joys. We’re talking about nerve pain, that stubborn, burning ache often linked to diabetes or shingles, and the unpredictable struggle of fibromyalgia or epilepsy. Walking through these storms, folks I’ve met—grandparents, teachers, even mechanics—want something better than just “managing.” They’re searching for a way back to themselves. In clinics and across kitchen tables, the conversation keeps steering toward Pregabalin, a medication that’s steadily become a lifeline for many dealing with chronic pain and certain seizures.
Pregabalin belongs to a family of medicines called anticonvulsants. At its heart, it’s designed to quiet the abnormal nerve signals that make pain feel intense or unstoppable, and it also steadies the electrical activity that can trigger seizures. The most common form you’ll find comes as capsules, although there’s a solution version for those who struggle with swallowing pills, an important touch that makes daily life just a bit easier. Usual capsule strengths vary from 25 mg up to 300 mg, which gives doctors room to tailor a dose that makes sense for each person’s needs.
For nerve pain brought on by conditions like diabetic neuropathy or shingles, Pregabalin’s strength shows up in stories I’ve heard: a woman able to hold her grandchild again, a musician picking up his guitar after months of numbness and burning. It turns down pain signals working overtime, letting normal touch feel normal again—and for those with fibromyalgia, it doesn’t sleep on the job, either. One patient compared her previous medications to “putting a Band-Aid on a thunderstorm,” but she found Pregabalin gave consistent relief when others would wear off or stop working.
In the real world, pills that lose their punch halfway through the day aren’t much help. Pregabalin offers steady coverage, usually needing to be taken twice daily. This fits more smoothly into routines compared to medicines that demand strict schedules or multiple daily doses. Most folks take it by mouth, and the option for an oral solution saves headaches for anyone dealing with swallowing problems, a challenge that pops up more than we often admit, especially with age or after surgeries.
Pregabalin’s chemical structure might sound like it belongs in a textbook, but the key is its targeted action. It binds to certain channels in the nervous system, blocking calcium and calming nerves before pain even fully develops. Unlike older treatments that “blanket” the whole brain, causing heavy sedation or memory trouble, Pregabalin aims for the signals you want to turn down—less collateral trouble for daily focus, reading, or driving.
Comparing pain medications can feel a lot like comparing apples and oranges. Some pick gabapentin because it’s been around longer, but gabapentin needs a slow climb in dosing and often leads to fuzziness or daytime sleep. Others land on antidepressants for nerve pain management, but dry mouth, weight gain, and bursts of drowsiness are tough pills to swallow—literally and figuratively.
What stands out with Pregabalin is both the speed and reliability of relief. I’ve watched friends and readers try medication after medication, discouraged by treatments that barely scratch the surface. Most tell me Pregabalin starts making a dent in pain within a week, sometimes even sooner. Studies back this up: controlled trials found noticeable changes in pain scores and quality of life within days, not weeks, of getting started. That’s a breath of hope when the days drag by and sleep keeps slipping away.
It’s not a magic bullet. Side effects like dizziness or sleepiness still happen, especially early on or when increasing the dose, but many find those problems tend to settle after a couple weeks. For people on complicated medication schedules, Pregabalin keeps things reassuringly simple—it doesn’t wreck blood sugar for diabetics, doesn’t jack up blood pressure, and it’s cleared by the kidneys, dodging a lot of nasty liver side effects that crop up with older drugs.
So many conversations about chronic nerve pain or seizures circle around the personal costs—missed workouts, afternoons spent in dark rooms, or jobs lost. The thing that doesn’t come up much in guidelines or sales pitches is how a medicine feels in real life. People with nerve pain aren’t just looking for numbers on a chart or a promise from a commercial. They need the ability to tie shoes, take a walk, or remember why they walked into a room.
Pregabalin holds a different lane compared to more sedating options. One veteran told me he could finally complete a shift as a security guard after years of switching medicines. Several parents noted their ability to concentrate improved. This difference often comes down to what Pregabalin doesn't try to do: it doesn’t knock you out or fog your head, so you get a shot at better days—real, measurable improvements in what matters most to you.
No one I’ve met expects miracles from a pill. Side effects don’t hit everyone the same way; some report swelling in the feet or blurry vision. Like any medication, there’s a risk of interactions—especially with alcohol or other drugs that slow the system. Pregabalin isn’t right for everyone: people with advanced kidney issues need close monitoring and may require adjusted doses.
There’s also a rising awareness (especially in the last decade) of possible misuse. Although Pregabalin doesn’t spur classic cravings like opioids, some try to push the limits by mixing it with other medications or alcohol. This has prompted medical societies and regulators in several countries to add extra checks and counseling for folks starting Pregabalin, making sure the benefits stay clear of unnecessary problems.
In most of the stories shared around town halls and clinics, what sticks with me isn’t just the science, but the ripple effect on community. People using Pregabalin describe feeling present again—returning to old hobbies, relationships, and sometimes even work after long absences. Chronic pain isolates in ways that are hard for outsiders to picture. Effective management, with a medicine that has less day-to-day cumbersome routines, means fewer missed birthdays or skipped outings because the pain is finally pushed into the background.
Another key differentiator is consistency. Pregabalin’s absorption doesn’t fluctuate much, no matter what you’ve eaten that day—a meaningful difference for busy folks who can’t plan every meal around pill schedules like older drugs sometimes demand. That reliability gives confidence not just to the person taking it, but to families and caregivers juggling everything else.
A medicine means little if it stays locked away by high prices. In the years right after its introduction, Pregabalin’s cost forced a tough decision at the pharmacy for many families. Since then, generic versions have come to market in most regions, which cut the cost and made real relief available without hard trade-offs between food, heat, and medication. Still, some insurance plans stick to older, cheaper options first. Persuading coverage often depends on proof of tried-and-failed alternatives, which means extra paperwork and waiting games.
Conversation with pharmacists and social workers points to a need for upfront, honest talk about cost even before the first prescription. Patient assistance plans and discounts have expanded, but awareness lags behind. In my view, part of responsible care means making sure no prescription sits forgotten in a cabinet simply because a family can’t shoulder the bill.
It’s easy to fall into the trap of thinking all pain relievers or anti-epileptics work the same. Yet, I’ve seen Pregabalin step up in ways few others manage. Compared to its older cousin gabapentin, Pregabalin tends to go to work faster, with steadier pain relief and fewer ups and downs between doses. Switching back and forth shows most people notice the difference—not just in fewer pills or less fatigue, but in control over symptoms without minute-by-minute anxiety about the next flare.
For many, opioids can manage severe pain, but long-term use brings a high risk of dependence and life-altering side effects: constipation, grogginess, and the shadow of addiction risk. Antidepressants prescribed for nerve pain—like amitriptyline—come with their own cluster of hurdles, especially for older patients sensitive to mental cloudiness or dangerously low blood pressure. Pregabalin aims for the pain without blunting mood or energy the way some antidepressants do. Those starting it for seizure control often find a smoother adjustment with fewer drastic mood shifts.
Every person’s journey with nerve pain or seizures is different—different triggers, routines, support systems. In my work and life, I’ve learned the best results come when people get a voice in what comes next. Pregabalin doesn’t demand complex preparation. Its flexibility lets patients and doctors adjust the dose fairly quickly, aiming for relief instead of just sedation or distraction. A good relationship between patient, family, and care team makes a world of difference here.
I’ve seen communities teach each other the steps: paying attention to side effects, taking notes about what helps most, having honest talks about hopes and limits. This kind of support not only keeps Pregabalin users safer and more confident; it also adapts as needs change, whether someone returns to work, starts new projects, or ages into new health needs.
Recent years brought new awareness to how invisible pain shapes lives. Medical professionals, patients, and advocates now speak with greater urgency about offering tools that work in the real world—not just on a printout or a number scale. Pregabalin made a place for itself by balancing relief with a sensible safety profile, standing strong where older medicines fade or cause bigger trade-offs.
Friends and neighbors talk about goals that once seemed out of reach: attending a graduation, taking a road trip, even just walking the dog around the block. What Pregabalin provides isn’t just a reduction on a pain chart; it’s a return to routines, a boost in independence, and in many cases, a step back toward living, not just enduring.
No medicine changes a life if it stays out of reach due to price or lack of information. Broadening access starts by pressing insurance agencies and pharmacy chains to keep generic options available and visible, not tucked away behind endless paperwork. Making sure prescribers and patients understand where Pregabalin fits—why it differs from gabapentin, why it’s safer than long-term opioid use—calls for richer conversations in exam rooms, reinforced by clear, readable materials in clinics and online.
For families and caregivers, education can dispel the myths swirling around chronic pain and seizure care. Free community workshops and transparent talks at town halls offer real hope, connecting those facing hardship with information they can actually use day to day. Patient advocacy groups, pharmacists, and clinicians need to keep working together, making sure up-to-date education spreads in plain language.
In the end, every solution circles back to the people caught in the mess of pain or unpredictable seizures—the folks who just want their lives back. Pregabalin, with all its strengths and imperfections, marks an important shift: a move toward medicines designed to respect everyday life. The trust it’s earned in clinics and homes comes from real stories, real trial and error, and a genuine desire for something better than just resignation. It isn’t about erasing pain completely, but about loosening its grip so those who’ve carried it longest can look forward to more than just one good day at a time.
The arc of Pregabalin’s story tracks closely with the stories I’ve grown up around—people facing long odds, picking themselves up after setbacks, and looking for the smallest edge that lets them move forward. Its place in the modern medicine cabinet isn’t carved in stone, but built on day-to-day results. By keeping the focus on what matters—relief that lasts, routines that can be trusted, and education that puts real information in real hands—Pregabalin carves out more than just a niche. It lays down a challenge for every pain and seizure medicine: put people first, respect the complexity of real life, and don’t pretend a pill alone is ever the whole answer.